R. Michael Carruthers - 24 Jun 2021 Form 3 Insider Report for Elevation Oncology, Inc. (ELEV)

Role
Director
Signature
/s/ Shawn Leland, Attorney-in-Fact
Issuer symbol
ELEV
Transactions as of
24 Jun 2021
Net transactions value
$0
Form type
3
Filing time
24 Jun 2021, 18:07:10 UTC
Next filing
19 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ELEV Employee Stock Option (Right to Buy) 24 Jun 2021 Common Stock 47,330 $3.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as of 1/12th of the total shares quarterly beginning on May 7, 2021 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date and is subject to acceleration in the event of a change in control of the Issuer.